Heme oxygenase agonists-fluvoxamine, melatonin-are efficacious therapy for Covid-19

被引：5
|
作者：
Hooper, Philip L. [1 ]
机构：
[1] Univ Colorado Anschutz Med Campus, Dept Med, Div Endocrinol & Metab, Aurora, CO 80045 USA
来源：
CELL STRESS & CHAPERONES | 2022年 / 27卷 / 01期
关键词：
D O I：
10.1007/s12192-021-01246-w
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [21] Melatonin, aging, and COVID-19: Could melatonin be beneficial for COVID-19 treatment in the elderly?
    Ozturk, Guler
    Akbulut, Kazime Gonca
    Guney, Sevin
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2020, 50 (06) : 1504 - 1512
  • [22] Overview of the potential use of fluvoxamine for COVID-19 and long COVID
    Hashimoto K.
    [J]. Discover Mental Health, 3 (1):
  • [23] Hemin as a novel candidate for treating COVID-19 via heme oxygenase-1 induction
    Kim, Dong-Hwi
    Ahn, Hee-Seop
    Go, Hyeon-Jeong
    Kim, Da-Yoon
    Kim, Jae-Hyeong
    Lee, Joong-Bok
    Park, Seung-Yong
    Song, Chang-Seon
    Lee, Sang-Won
    Ha, Sang-Do
    Choi, Changsun
    Choi, In-Soo
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [24] Hemin as a novel candidate for treating COVID-19 via heme oxygenase-1 induction
    Dong-Hwi Kim
    Hee-Seop Ahn
    Hyeon-Jeong Go
    Da-Yoon Kim
    Jae-Hyeong Kim
    Joong-Bok Lee
    Seung-Yong Park
    Chang-Seon Song
    Sang-Won Lee
    Sang-Do Ha
    Changsun Choi
    In-Soo Choi
    [J]. Scientific Reports, 11
  • [25] Heme oxygenase-1 modulation: A potential therapeutic target for COVID-19 and associated complications
    Singh, Devendra
    Wasan, Himika
    Reeta, K. H.
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2020, 161 : 263 - 271
  • [26] Old drug fluvoxamine, new hope for COVID-19
    Yaeko Hashimoto
    Takuji Suzuki
    Kenji Hashimoto
    [J]. European Archives of Psychiatry and Clinical Neuroscience, 2022, 272 : 161 - 163
  • [27] Mechanisms of action of fluvoxamine for COVID-19: a historical review
    Hashimoto, Yaeko
    Suzuki, Takuji
    Hashimoto, Kenji
    [J]. MOLECULAR PSYCHIATRY, 2022, 27 (04) : 1898 - 1907
  • [28] Mechanisms of action of fluvoxamine for COVID-19: a historical review
    Yaeko Hashimoto
    Takuji Suzuki
    Kenji Hashimoto
    [J]. Molecular Psychiatry, 2022, 27 : 1898 - 1907
  • [29] Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
    Bramante, C. T.
    Huling, J. D.
    Tignanelli, C. J.
    Buse, J. B.
    Liebovitz, D. M.
    Nicklas, J. M.
    Cohen, K.
    Puskarich, M. A.
    Belani, H. K.
    Proper, J. L.
    Siegel, L. K.
    Klatt, N. R.
    Odde, D. J.
    Luke, D. G.
    Anderson, B.
    Karger, A. B.
    Ingraham, N. E.
    Hartman, K. M.
    Rao, V
    Hagen, A. A.
    Patel, B.
    Fenno, S. L.
    Avula, N.
    Reddy, N., V
    Erickson, S. M.
    Lindberg, S.
    Fricton, R.
    Lee, S.
    Zaman, A.
    Saveraid, H. G.
    Tordsen, W. J.
    Pullen, M. F.
    Biros, M.
    Sherwood, N. E.
    Thompson, J. L.
    Boulware, D. R.
    Murray, T. A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (07): : 599 - 610
  • [30] Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    [J]. INFECTION AND CHEMOTHERAPY, 2022, 54 (02): : 369 - 369
12345